WKRC: Local researchers working on a new potential way to treat eye diseases
UC led research may soon have a new kinder, gentler way to treat eye diseases.
UC drug delivery researcher Kevin Li, a professor in the James L. Winkle College of Pharmacy, takes the lead on new research looking for different ways to treat eye diseases such as macular degeneration and diabetic retinopathy. Currently, these diseases are treated with direct eye injections.
In an interview with WKRC, co-researcher Michael Yang, a pediatric ophthalmologist at Cincinnati Children’s Hospital Medical Center, explains how this federally funded study will seek alternatives to current drug delivery methods.
The study is a collaboration between UC, CCHMC and Ohio State University.
Featured image at top of eye. Photo/Victor Freitas/unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Meet the young talent reshaping Cincinnati’s startup scene
October 28, 2025
Five University of Cincinnati students were honored for their impactful entrepreneurship on the Cincy Inno Under 25 list. We’ll explain what makes each student – and their startup – stand out.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.